111 Peter Street
Suite 300
Toronto, ON M5V 2H1
Canada
416 504 0004
https://www.thecronosgroup.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 356
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Michael Ryan Gorenstein J.D. | President, CEO & Chairman | 3,94M | 89,3k | 1987 |
Mr. James Holm | Chief Financial Officer | 314,31k | N/A | 1983 |
Mr. Jeffrey David Jacobson | Chief Growth Officer | 730,12k | 363k | 1986 |
Ms. Anna Shlimak | Senior Vice President of Corporate Affairs & Strategy | 530,5k | N/A | 1986 |
Mr. James Andrew McGinness III | VP, Controller & Principal Accounting Officer | N/A | N/A | 1979 |
Mr. Shayne J. Laidlaw | Director of Investor Relations & Strategy | N/A | N/A | N/A |
Mr. Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary | N/A | N/A | 1990 |
Ms. Shannon Buggy | Senior VP & Global Head of People | 438,81k | N/A | 1970 |
Mr. Arye Weigensberg | Senior VP & Head of Research and Development | N/A | N/A | 1983 |
Mr. Adam Wagner | Senior VP & Head of Cronos Israel | N/A | N/A | N/A |
O QualityScore de governança da ISS da Cronos Group Inc. a partir de 1 de abril de 2024 é 10. As principais pontuações para Auditoria são: 10; Conselho: 8; Direitos de Acionistas: 6; Compensação: 10.